Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
1 day ago · BOSTON--(BUSINESS WIRE)--Jan. 30, 2025-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has …
FDA approves painkiller designed to eliminate risks of addiction ...
17 hours ago · The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new …
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
17 hours ago · BOSTON, January 30, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved …
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
17 hours ago · The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. ... To test the drug, Vertex, which is based in Boston, conducted two …
Vertex Announces FDA Approval of JOURNAVX ... - Business Wire
1 day ago · BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved …
Vertex Announces FDA Acceptance of New Drug Application for …
Jul 30, 2024 · BOSTON -- (BUSINESS WIRE)--Jul. 30, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration …
FDA approves Vertex’s acute pain treatment Journavx - Yahoo …
7 hours ago · The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with acute pain. The FDA has …
Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA …
1 hour ago · Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration. The drugmaker said the twice-daily pill, Journavx, is the first such …
Vertex Announces U.S. FDA Approval for TRIKAFTA …
Dec 20, 2024 · BOSTON--(BUSINESS WIRE)--Dec. 20, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration ...
FDA signs off on Vertex’s non-opioid pain reliever Journavx
14 hours ago · Vertex Pharmaceuticals has scored an FDA approval for Journavx (suzetrigine), a non-opioid pain reliever that could usher in a new era of nonaddictive therapy in the …
- Some results have been removed